The Latest Breaking News from Pfizer

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

It's only November — but if you're like most investors — 2024 is what matters now. And some S&P 500 companies already look primed to put up big numbers.

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Social media users shared a range of false claims this week

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

Rodgers isn't coming back from that one.

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Stock market indexes took a tumble Monday after Moody's Investor's Service cut its rating on U.S. debt. Boeing surged on deal news.

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.